Skip to content

Probiotics and Hospital Outcome in the Elderly

Effects of Commercially Available Probiotics on Hospital Outcome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00794924
Acronym
PROAGE
Enrollment
345
Registered
2008-11-20
Start date
2004-02-29
Completion date
2005-01-31
Last updated
2008-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation, Diarrhea

Keywords

probiotics, elderly, motility, diarrhea

Brief summary

Probiotics have been shown to reduce the rate of diarrhea and constipation. The purpose of this study was to investigate if probiotics could improve outcome of hospitalized orthopedic elderly patients.

Detailed description

The patients were divided into two groups. One received probiotics for 45 days and the second received placebo. The patients had a clinical and epidemiological as well as nutritional assessment. They were followed-up as for their bowel movements, abdominal pain and nosocomial infections and for the incidence of helicobacter pylori and clostridiume difficille diarrhea.

Interventions

DIETARY_SUPPLEMENTVSL#3

one sachet per day, for 45 consecutive days

DIETARY_SUPPLEMENTplacebo

one sachet per day, for 45 consecutive days

Sponsors

Kaplan-Harzfeld Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who were hospitalized in the Department of Geriatric Orthopedic Rehabilitation a week before their enrollment in the study and signed an informed consent.

Exclusion criteria

* Known or suspected allergy to any probiotics * Neutropenia * Inability to sign an informed consent

Design outcomes

Primary

MeasureTime frameDescription
Reduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group45 days of measuring the outcomeGastrointestinal motility was assessed by the number of days a patient was constipated or had diarrhea.

Secondary

MeasureTime frame
Improvement in Nutritional and Immunological Measurements45 days

Participant flow

Recruitment details

February 2004 to january 2005, all patients admitted to the Geriatric Rehabilitation Department of the Harzfeld Geriatric Mdical Center

Participants by arm

ArmCount
Probiotics
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received commercially available probiotics (VSL#3) for 45 days.
174
Placebo
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received placebo sachets for 45 days.
171
Total345

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event62
Overall StudyLost to Follow-up68
Overall StudyWithdrawal by Subject4860

Baseline characteristics

CharacteristicProbioticsPlaceboTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
169 Participants165 Participants334 Participants
Age, Categorical
Between 18 and 65 years
5 Participants6 Participants11 Participants
Age Continuous76.4 years
STANDARD_DEVIATION 8.5
75.7 years
STANDARD_DEVIATION 8.6
76.05 years
STANDARD_DEVIATION 8.6
Sex: Female, Male
Female
90 Participants80 Participants170 Participants
Sex: Female, Male
Male
84 Participants91 Participants175 Participants

Outcome results

Primary

Reduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group

Gastrointestinal motility was assessed by the number of days a patient was constipated or had diarrhea.

Time frame: 45 days of measuring the outcome

Population: The number of participants was chosen in order to receive a difference by GEE statistical model with \> 0.05 p value. The analysis was done per protocol.

ArmMeasureValue (MEAN)Dispersion
ProbioticsReduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group12 days of constipation or diarrheaStandard Deviation 2.4
PlaceboReduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group19 days of constipation or diarrheaStandard Deviation 3.9
Secondary

Improvement in Nutritional and Immunological Measurements

Time frame: 45 days

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026